XML 48 R25.htm IDEA: XBRL DOCUMENT
v3.21.1

Investments (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2021
Investments [Abstract] |
Schedule of Long-term Investments | The below equity investments are included in investments on the condensed consolidated balance sheets (in thousands):
|  | March 31, 2021 |  | December 31, 2020
Respicardia Inc. (1) (2) |  | $ | 21,796 |  |  | $ | 17,706 |
ALung Technologies, Inc. (3) |  | 3,000 |  |  | 3,000 |
Ceribell, Inc. |  | 3,000 |  |  | 3,000 |
ShiraTronics, Inc. |  | 2,045 |  |  | 2,045 |
Noctrix Health, Inc. |  | 3,159 |  |  | 1,359 |
MD Start II |  | 1,174 |  |  | 1,227 |
Rainbow Medical Ltd. |  | 1,149 |  |  | 1,201 |
Highlife S.A.S. |  | 1,113 |  |  | 1,163 |
|  | 36,436 |  |  | 30,701 |
Equity method investment |  | 336 |  |  | 393 |
|  | $ | 36,772 |  |  | $ | 31,094 |
(1)Respicardia Inc. (“Respicardia”) is a privately funded U.S. company developing an implantable device designed to restore a more natural breathing pattern during sleep in patients with central sleep apnea by transvenously stimulating the phrenic nerve. We have a loan outstanding to Respicardia, with a carrying amount of $1.3 million and $0.8 million as of March 31, 2021 and December 31, 2020, respectively, which is included in prepaid expenses and other current assets on the condensed consolidated balance sheet. (2)In April 2021, Zoll Medical Corporation acquired Respicardia Inc. As a result of the acquisition we received proceeds of $23.1 million for our investment and loan receivable with carrying values of $17.7 million and $0.8 million as of December 31, 2020, respectively. The Company recorded a gain of $4.6 million during the first quarter of 2021 to adjust the investment and loans receivable to fair value, which is included in foreign exchange and other losses on the condensed consolidated statement of income (loss). (3)ALung Technologies, Inc. (“ALung”) is a privately held medical device company focused on creating advanced medical devices for treating respiratory failure. ALung’s Hemolung Respiratory Assist System is a dialysis-like alternative or supplement to mechanical ventilation which removes carbon dioxide directly from the blood in patients with acute respiratory failure. We have a loan outstanding to ALung, with a carrying amount of $2.5 million and $2.5 million as of March 31, 2021 and December 31, 2020, respectively, which is included in prepaid expenses and other current assets on the condensed consolidated balance sheet.

X
- Definition Tabular disclosure of investment in equity security without readily determinable fair value. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 321 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=120269885&loc=SL75117539-209714 + Details
Name: | us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_InvestmentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration